Home
About
Publications Trends
Recent Publications
Expert Search
Archive
glutaminase
What is Glutaminase?
Glutaminase is an enzyme responsible for the conversion of
glutamine
to
glutamate
and ammonia. This process, known as glutaminolysis, plays a crucial role in cellular metabolism, particularly in rapidly proliferating cells like cancer cells.
Frequently asked queries:
What is Glutaminase?
Why is Glutaminase Important in Cancer?
How Does Glutaminase Affect Tumor Growth?
Can Targeting Glutaminase be a Therapeutic Strategy?
What are Some Glutaminase Inhibitors in Development?
What Challenges are Associated with Targeting Glutaminase?
Are There Long-Term Benefits of Immunotherapy?
How Does Region Growing Work?
How to Prepare for Preoperative Testing?
What Are the Benefits of Having a DMC?
Can Hair Loss Be Prevented?
Why is Gastroscopy Important in Cancer Diagnosis?
What are Some Applications of Kaplan-Meier Curves in Cancer Research?
What is the Connection Between Immunosuppressive Drugs and Cancer?
What is Multi-Omics?
What Role Do Genetic Tests Play?
What is the Role of Genetic Markers in Cancer Diagnosis?
Why are Pathological Audits Important in Cancer?
Are There Specific Cancers Linked to Iron Dysregulation?
What is Data Transformation in Cancer Research?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe